| Maybe I can offer a little insight into the "smart" drug topic. I work in employee benefits and one of the single most scrutinized aspects, over the last several years, is the ever increasing cost associated with the provision of prescription drugs. I just got back from a benefits conference that had some seminars around the genomic research and it's potential applications. My layman's take on this, is that smart drugs are going to stem from genomic research that will be able to target specific propensities to conditions. The smart drugs will be expensive to produce and have limited applications, ie, only applicable to specific conditions that can be traced to people with specific propensity for the ailment, so limited markets. Blockbuster drugs, like Viagara, have historically paid for research into these condition specific drugs. They are coming, maybe even arthritis focused but they are a long way out there. So the delivery system that DMX offers is still leading edge, in my opinion, especially as an arthritis sufferer...what I would like to do, is sample the stuff...how can I do that...Vancouver resident? |
